De Grandis D - Search Results

1

The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans.

Eleopra R, Tugnoli V, De Grandis D. Eleopra R, et al. Among authors: de grandis d. Mov Disord. 1997 Jan;12(1):89-94. doi: 10.1002/mds.870120115. Mov Disord. 1997. PMID: 8990059

2

Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting.

Eleopra R, Tugnoli V, Quatrale R, Gastaldo E, Rossetto O, De Grandis D, Montecucco C. Eleopra R, et al. Among authors: de grandis d. Clin Neurophysiol. 2002 Aug;113(8):1258-64. doi: 10.1016/s1388-2457(02)00103-7. Clin Neurophysiol. 2002. PMID: 12140005

3

Botulinum toxin treatment in the facial muscles of humans: evidence of an action in untreated near muscles by peripheral local diffusion.

Eleopra R, Tugnoli V, Caniatti L, De Grandis D. Eleopra R, et al. Among authors: de grandis d. Neurology. 1996 Apr;46(4):1158-60. doi: 10.1212/wnl.46.4.1158. Neurology. 1996. PMID: 8780112

4

Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human.

Eleopra R, Tugnoli V, Rossetto O, Montecucco C, De Grandis D. Eleopra R, et al. Among authors: de grandis d. Neurosci Lett. 1997 Mar 14;224(2):91-4. doi: 10.1016/s0304-3940(97)13448-6. Neurosci Lett. 1997. PMID: 9086464 Clinical Trial.

5

Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.

Eleopra R, Tugnoli V, Rossetto O, De Grandis D, Montecucco C. Eleopra R, et al. Among authors: de grandis d. Neurosci Lett. 1998 Nov 13;256(3):135-8. doi: 10.1016/s0304-3940(98)00775-7. Neurosci Lett. 1998. PMID: 9855358 Clinical Trial.

6

Management of parotid sialocele with botulinum toxin.

Marchese Ragona R, Blotta P, Pastore A, Tugnoli V, Eleopra R, De Grandis D. Marchese Ragona R, et al. Among authors: de grandis d. Laryngoscope. 1999 Aug;109(8):1344-6. doi: 10.1097/00005537-199908000-00032. Laryngoscope. 1999. PMID: 10443847 No abstract available.

7

The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A.

Tugnoli V, Marchese Ragona R, Eleopra R, Quatrale R, Capone JG, Pastore A, Montecucco C, De Grandis D. Tugnoli V, et al. Among authors: de grandis d. Clin Auton Res. 2002 Jun;12(3):174-8. doi: 10.1007/s10286-002-0026-x. Clin Auton Res. 2002. PMID: 12269549

8

The therapeutic use of botulinum toxin.

Tugnoli V, Eleopra R, Montecucco C, De Grandis D. Tugnoli V, et al. Among authors: de grandis d. Expert Opin Investig Drugs. 1997 Oct;6(10):1383-94. doi: 10.1517/13543784.6.10.1383. Expert Opin Investig Drugs. 1997. PMID: 15989508

9

On the action of botulinum neurotoxins A and E at cholinergic terminals.

Washbourne P, Pellizzari R, Rossetto O, Bortoletto N, Tugnoli V, De Grandis D, Eleopra R, Montecucco C. Washbourne P, et al. Among authors: de grandis d. J Physiol Paris. 1998 Apr;92(2):135-9. doi: 10.1016/S0928-4257(98)80151-4. J Physiol Paris. 1998. PMID: 9782457

10

Hyperhidrosis and sympathetic skin response in chronic alcoholic patients.

Tugnoli V, Eleopra R, De Grandis D. Tugnoli V, et al. Among authors: de grandis d. Clin Auton Res. 1999 Feb;9(1):17-22. doi: 10.1007/BF02280692. Clin Auton Res. 1999. PMID: 10212744 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters